Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pancreatic Neoplasms × Trastuzumab × Clear all

Sponsor

Conditions

Breast Neoplasms 208 Stomach Neoplasms 17 Neoplasm Metastasis 13 Breast Neoplasms, Male 13 Neoplasms 8 Esophageal Neoplasms 8 Brain Neoplasms 7 Inflammatory Breast Neoplasms 6 Colorectal Neoplasms 4 Adenocarcinoma Of Esophagus 4 Triple Negative Breast Neoplasms 3 Urologic Neoplasms 2 HER2-positive Breast Cancer 2 Gallbladder Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Ductal, Breast 2 Adenocarcinoma 2 Urinary Bladder Neoplasms 1 Solid Cancers 1 Rectal Neoplasms 1 Patient Preference 1 Patient Compliance 1 Osteitis Deformans 1 Neoplasm, Residual 1 Meningeal Neoplasms 1 Malignant Solid Neoplasm 1 Locally Advanced Breast Cancer 1 Lethal Congenital Contracture Syndrome 2 1 Hormone Receptor Positive Breast Cancer 1

Interventions

Gemcitabine 141 Fluorouracil 41 Capecitabine 39 130-nm albumin-bound paclitaxel 39 Oxaliplatin 37 Albumin-Bound Paclitaxel 35 Leucovorin 31 Erlotinib Hydrochloride 29 Radiotherapy 20 Irinotecan 20 Bevacizumab 19 pembrolizumab 18 Radiosurgery 16 Docetaxel 16 Cyclophosphamide 15 Taxes 11 Cisplatin 11 Cetuximab 11 folfirinox 9 Nivolumab 9 Ipilimumab 7 Standard of Care 6 Radiation 6 spartalizumab 5 durvalumab 5 dehydroftorafur 5 Surgical Procedures, Operative 5 Paclitaxel 5 Hydroxychloroquine 5 Ascorbic Acid 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡